Cargando…
Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure
RATIONALE: Despite advances in pharmacotherapy, heart failure still incurs significant morbidity and mortality. Stimulating antibodies directed against the secondextracellular loop of the human ß(1)-adrenergic receptor (anti-ß(1)EC2) cause myocyte damage and heart failure in rats. This receptor doma...
Autores principales: | Boivin-Jahns, Valérie, Uhland, Kerstin, Holthoff, Hans-Peter, Beyersdorf, Niklas, Kocoski, Vladimir, Kerkau, Thomas, Münch, Götz, Lohse, Martin J., Ungerer, Martin, Jahns, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101361/ https://www.ncbi.nlm.nih.gov/pubmed/30125285 http://dx.doi.org/10.1371/journal.pone.0201160 |
Ejemplares similares
-
Novel Receptor-Derived Cyclopeptides to Treat Heart Failure Caused by Anti-β(1)-Adrenoceptor Antibodies in a Human-Analogous Rat Model
por: Boivin, Valérie, et al.
Publicado: (2015) -
Prevalence of anti‐beta‐1 antibody 6 months after hospitalization for acute heart failure predicts adverse outcome
por: Morbach, Caroline, et al.
Publicado: (2023) -
Unmasking features of the auto‐epitope essential for β(1)‐adrenoceptor activation by autoantibodies in chronic heart failure
por: Wölfel, Angela, et al.
Publicado: (2020) -
Overexpression of ABCG1 protein attenuates arteriosclerosis and endothelial dysfunction in atherosclerotic rabbits
por: Münch, Götz, et al.
Publicado: (2012) -
Review of Mouse Models of Graves’ Disease and Orbitopathy—Novel Treatment by Induction of Tolerance
por: Ungerer, Martin, et al.
Publicado: (2016)